These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2005-001925-27 Phase I/II clinical trial of T cell suicide gene therapy following haploidentical stem cell transplantation 2013-01-10 not-yet-due
Completed, but no date Terminated 2005-002148-25 A double blind randomised control trial of perioperative glutamine administration: a potential therapy for preventing post-operative immune hypo-responsiveness. bad-data
Reported results 2005-004122-70 Immunogenicity of conjugate pneumococcal vaccine (Prevenar) in patients with ataxia -telangiectasia (AT) including a randomised study of one versus two doses of vaccine. 2008-03-27 due-trials
Reported results 2006-000675-15 Open label Randomised Controlled Trial comparing povidone-iodine 10% with alcohol and 0.5% chlorhexidine with alcohol for prevention of early infection associated with insertion of central venous acce... 2007-10-18 due-trials
Exempt Terminated 2010-018447-34 Investigation of dendritic cell vaccine immunotherapy in paediatric high grade glioma 2014-07-09 not-yet-due
Exempt 2010-020797-41 NEMO-1: An open label exploratory dose finding and pharmacokinetic clinical trial of bumetanide for the treatment of NEonatal seizure using Medication Off-patent. 2012-11-13 not-yet-due
Exempt, with results 2010-024253-36 Phase I/II, historical controlled, open-label, non-randomised, single-centre trial to assess the safety and efficacy of EF1αS-ADA lentiviral vector mediated gene modification of autologus CD34+ cells ... 2019-12-23 not-yet-due
Reported results 2012-003790-25 Comparison of measured versus predicted blood propofol concentrations in children undergoing spinal surgery 2013-07-03 due-trials
Exempt, with results 2013-000015-24 90-Yttrium-labelled anti-CD66 monoclonal antibody as part of a reduced intensity conditioning regimen prior to allogeneic haematopoietic stem cell transplantation: an open label, dose escalating phase... 2020-05-14 not-yet-due
Reported results 2013-003257-20 Evaluation of Treosulfan pharmacokinetics (PK) in children undergoing allogeneic haematopoietic stem cell transplantation (HSCT) 2017-12-15 due-trials
Reported results Terminated 2014-002996-27 Optimising effectiveness and minimising toxicity of intravenous salbutamol in children with acute asthma 2017-06-30 due-trials
Reported results 2014-004272-29 Phase II clinical trial to evaluate safety and efficacy of mobilisation and collection of CD34+ cells after treatment with plerixafor and filgrastim in patients with Fanconi anaemia for subsequent tra... 2018-01-23 due-trials
Other 2017-001275-23 Efficacy and safety of a cryopreserved formulation of autologous CD34+ haematopoietic stem cells transduced ex vivo with EFS lentiviral vector encoding for human ADA gene in subjects with Severe Combi... not-yet-due
Other 2017-002635-41 A paediatric phase I/II study of intermittent dosing of the MEK-1 inhibitor selumetinib in children with neurofibromatosis type-1 and inoperable plexiform neurofibroma and/or progressive optic pathway... not-yet-due
Other 2017-004539-36 Study of Montelukast In Children with Sickle Cell Disease (SMILES) not-yet-due
Exempt 2018-000673-68 Phase I/II study of lentiviral gene transfer for SCID-X1 with low dose targeted busulfan not-yet-due
Other 2019-003025-22 PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial not-yet-due
Exempt 2019-003462-40 Phase 1 , open label study of CRISPR-CAR genome edited T cells (TT52CAR19) in relapsed /refractory B Cell Acute Lymphoblastic Leukaemia not-yet-due